share_log

Danimer Scientific, Inc. (NYSE:DNMR) Shares Purchased by Trellus Management Company LLC

Danimer Scientific, Inc. (NYSE:DNMR) Shares Purchased by Trellus Management Company LLC

DAnimer Science,Inc.(紐約證券交易所市場代碼:DNMR)由Trellus Management Company LLC購買的股票
Financial News Live ·  2022/09/20 12:51

Trellus Management Company LLC raised its position in shares of Danimer Scientific, Inc. (NYSE:DNMR – Get Rating) by 114.5% during the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 122,926 shares of the company's stock after buying an additional 65,626 shares during the quarter. Danimer Scientific comprises 0.7% of Trellus Management Company LLC's portfolio, making the stock its 26th largest position. Trellus Management Company LLC owned approximately 0.12% of Danimer Scientific worth $561,000 at the end of the most recent quarter.

根據Trellus Management Company LLC向美國證券交易委員會(Securities&Exchange Commission)的最新披露,該公司在第二季度將其在DAnimer Science,Inc.(紐約證券交易所代碼:DNMR-GET Rating)的股票頭寸提高了114.5%。該機構投資者在本季度額外購買了65,626股後,持有該公司122,926股股票。丹尼默科學公司佔Trellus Management Company LLC投資組合的0.7%,使該股成為其第26大頭寸。截至最近一個季度末,Trellus Management Company LLC擁有丹尼默科學公司約0.12%的股份,價值561,000美元。

Several other institutional investors and hedge funds have also recently bought and sold shares of DNMR. SouthState Corp boosted its stake in Danimer Scientific by 280.0% during the 1st quarter. SouthState Corp now owns 5,130 shares of the company's stock valued at $30,000 after purchasing an additional 3,780 shares in the last quarter. Lazard Asset Management LLC acquired a new position in shares of Danimer Scientific in the 1st quarter valued at about $53,000. First Heartland Consultants Inc. acquired a new position in shares of Danimer Scientific in the 2nd quarter valued at about $58,000. Aspiriant LLC acquired a new position in shares of Danimer Scientific in the 1st quarter valued at about $59,000. Finally, Ergoteles LLC acquired a new position in shares of Danimer Scientific in the 1st quarter valued at about $66,000. Institutional investors and hedge funds own 44.98% of the company's stock.

其他幾家機構投資者和對衝基金最近也買入和賣出了DNMR的股票。南州公司在第一季度增持了丹尼默科學公司280.0%的股份。SouthState Corp目前持有該公司5,130股股票,價值3萬美元,此前該公司在上個季度又購買了3,780股股票。Lazard Asset Management LLC在第一季度收購了DAnimer Science的新頭寸,價值約53,000美元。第一心地諮詢公司在第二季度收購了價值約58,000美元的丹尼默科學公司的新股票頭寸。ASpiriant LLC在第一季度收購了DAnimer Science的新頭寸,價值約59,000美元。最後,Ergoeles LLC在第一季度收購了DAnimer Science的新頭寸,價值約66,000美元。機構投資者和對衝基金持有該公司44.98%的股票。

Get
到達
Danimer Scientific
丹尼默科學公司
alerts:
警報:

Danimer Scientific Stock Performance

DAnimer科學股票表現

Danimer Scientific stock traded down $0.14 during mid-day trading on Tuesday, hitting $3.54. 14,760 shares of the company were exchanged, compared to its average volume of 1,133,018. Danimer Scientific, Inc. has a 1-year low of $3.09 and a 1-year high of $20.40. The company has a debt-to-equity ratio of 0.56, a quick ratio of 5.53 and a current ratio of 6.60. The business has a fifty day moving average of $4.61 and a 200 day moving average of $4.66.

丹尼默科學公司的股票在週二午盤交易中下跌0.14美元,觸及3.54美元。該公司股票成交量為14,760股,而平均成交量為1,133,018股。DAnimer Science,Inc.的一年低點為3.09美元,一年高位為20.40美元。該公司的負債權益比率為0.56,速動比率為5.53,流動比率為6.60。該業務的50日移動均線切入位在4.61美元,200日移動均線切入位在4.66美元。

Danimer Scientific (NYSE:DNMR – Get Rating) last released its quarterly earnings results on Tuesday, August 9th. The company reported ($0.30) EPS for the quarter, missing analysts' consensus estimates of ($0.26) by ($0.04). Danimer Scientific had a negative net margin of 104.97% and a negative return on equity of 19.28%. The firm had revenue of $12.70 million during the quarter. Equities analysts predict that Danimer Scientific, Inc. will post -0.82 EPS for the current fiscal year.
DAnimer Science(紐約證券交易所股票代碼:DNMR-GET Rating)最近一次發佈季度收益報告是在8月9日,星期二。該公司公佈了該季度每股收益(0.30美元),低於分析師普遍預期的(0.26美元)和(0.04美元)。丹尼默科學公司的淨利潤率為負104.97%,淨資產回報率為負19.28%。該公司本季度的收入為1270萬美元。股票分析師預計,丹尼默科學公司本財年每股收益將達到0.82歐元。

Insider Transactions at Danimer Scientific

丹尼默科學公司的內幕交易

In other Danimer Scientific news, CMO Scott Tuten sold 10,000 shares of the company's stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $5.06, for a total value of $50,600.00. Following the sale, the chief marketing officer now owns 464,136 shares in the company, valued at $2,348,528.16. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, CMO Scott Tuten sold 10,000 shares of the company's stock in a transaction that occurred on Wednesday, August 17th. The stock was sold at an average price of $5.06, for a total value of $50,600.00. Following the transaction, the chief marketing officer now owns 464,136 shares of the company's stock, valued at $2,348,528.16. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Stuart W. Pratt sold 75,327 shares of the company's stock in a transaction that occurred on Thursday, August 18th. The shares were sold at an average price of $5.25, for a total value of $395,466.75. Following the completion of the transaction, the director now directly owns 1,519,238 shares in the company, valued at approximately $7,975,999.50. The disclosure for this sale can be found here. Insiders sold 95,327 shares of company stock valued at $496,867 over the last quarter. Corporate insiders own 14.60% of the company's stock.

在DAnimer Science的其他新聞中,首席營銷官斯科特·圖騰在8月17日星期三的一筆交易中出售了10,000股該公司股票。這隻股票的平均售價為5.06美元,總價值為50,600.00美元。出售後,首席營銷官現在擁有該公司464,136股,價值2,348,528.16美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過以下鏈接獲得。在其他新聞方面,首席營銷官斯科特·圖騰在8月17日星期三的一筆交易中出售了10,000股公司股票。這隻股票的平均售價為5.06美元,總價值為50,600.00美元。交易完成後,首席營銷官現在持有464,136股公司股票,價值2,348,528.16美元。這筆交易是在提交給美國證券交易委員會的一份文件中披露的,該文件可通過美國證券交易委員會網站獲得。此外,在8月18日(星期四)的一筆交易中,董事出售了75,327股該公司股票。這些股票的平均價格為5.25美元,總價值為395,466.75美元。交易完成後,董事現在直接擁有該公司1,519,238股股份,價值約7,975,999.50美元。此次拍賣的披露信息可在此處找到。內部人士在上個季度出售了95,327股公司股票,價值496,867美元。公司內部人士持有該公司14.60%的股份。

Wall Street Analyst Weigh In

華爾街分析師也加入進來

Separately, Cowen lowered their price target on Danimer Scientific to $6.00 in a research note on Monday, August 15th.

另外,考恩在8月15日星期一的一份研究報告中將丹尼默科學公司的目標價下調至6.00美元。

Danimer Scientific Company Profile

丹尼默科學公司簡介

(Get Rating)

(獲取評級)

Danimer Scientific, Inc, a performance polymer company, develops, produces, and provides bioplastic replacements for traditional petroleum-based plastics. It produces polyhydroxyalkanoate, a biodegradable plastic feedstock alternative used in a range of plastic applications, including films, straws, food containers, and other things under the Nodax brand name; polylactic acid-based resins for coating disposable paper cups; and other biopolymers.

丹尼默科學公司是一家高性能聚合物公司,開發、生產和提供傳統石油塑料的生物塑料替代品。該公司生產聚羥基烷酸酯,這是一種可生物降解的塑料原料替代品,用於一系列塑料應用,包括Nodax品牌的薄膜、吸管、食品容器和其他物品;用於一次性紙杯塗層的聚乳酸樹脂;以及其他生物聚合物。

Further Reading

進一步閲讀

  • Get a free copy of the StockNews.com research report on Danimer Scientific (DNMR)
  • Has AMD stock stock fallen too far?
  • Oracle's Short-Term Pain Could Be Your Long-Term Gain
  • Lucid is Looking Like a Clear EV Winner
  • Still Lovin' It: Investors Keep Visiting McDonald's
  • Did FedEx Just Deliver A Buying Opportunity?
  • 免費獲取StockNews.com關於丹尼默科學公司的研究報告(DNMR)
  • AMD股票是不是跌得太厲害了?
  • 甲骨文的短期痛苦可能是你的長期收益
  • Lucid看起來像是電動汽車的贏家
  • 仍然愛着它:投資者繼續光顧麥當勞
  • 聯邦快遞剛剛提供了一個買入機會嗎?

Receive News & Ratings for Danimer Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danimer Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

接受《動漫科技日報》的新聞和評級-在下面輸入您的電子郵件地址,通過MarketBeat.com的免費每日電子郵件時事通訊,接收對DAnimer Science及相關公司的最新新聞和分析師評級的每日簡要摘要。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論